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Background:  Testosterone therapy is widely used among men. Controversy persists regarding the effect of testosterone therapy on 
adverse cardiovascular events among men. Two recent studies have shown an increased risk of adverse cardiovascular events with 
testosterone therapy in men. We performed this meta-analysis to evaluate the effect of testosterone therapy on adverse cardiovascular 
events among men.
methods:  We performed a systematic literature search for studies evaluating effect of testosterone therapy versus no testosterone 
therapy on cardiovascular events among men. Studies providing data on the outcome of cardiovascular events were included. Statistical 
heterogeneity across the various trials was tested using the Cochran’s Q statistic and I2 was computed to quantify heterogeneity. A two-
sided alpha error of less than 0.05 was considered to be statistically significant (p < 0.05).
results:  Total of 29 eligible studies involving 122,889 men was included. The studies were heterogeneous; hence the random-effect 
model was used to calculate combined relative risk (RR). Meta-analysis revealed that testosterone therapy does not cause statistically 
significant adverse cardiovascular events among men (RR, 1.168; CI, 0.794 to 1.718; p = 0.431).
Conclusion:  Testosterone therapy may not be associated with adverse cardiovascular events among men. Future randomized controlled 
trials are necessary to characterize the effects of testosterone therapy on potential adverse cardiovascular events among men.
